Foresite Capital Management VI’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-244,900
Closed -$11.6M 13
2025
Q3
$11.6M Hold
244,900
4.49% 8
2025
Q2
$13.1M Sell
244,900
-120,100
-33% -$5.46M 7.35% 3
2025
Q1
$14.8M Hold
365,000
8.09% 5
2024
Q4
$10.2M Buy
+365,000
New +$11.1M 4.52% 8

Other funds holding AKRO